Logo image
n-3 PUFAs improve erythrocyte fatty acid profile in patients with small abdominal aortic aneurysms: a randomised controlled trial
Journal article   Open access   Peer reviewed

n-3 PUFAs improve erythrocyte fatty acid profile in patients with small abdominal aortic aneurysms: a randomised controlled trial

Lara T Meital, Mark Windsor, Rebecca M L Ramirez Jewell, Peter Young, Karl Schulze, Rebecca Magee, Jill O'Donnell, Pankaj Jha, Maria-Christina Perissiou, Jonathan Golledge, …
Journal of Lipid Research, Vol.60(6), pp.1154-1163
2019
pdf
n-3 PUFAs improve erythrocyte fatty acid profile in patients with small abdominal aortic aneurysms - a randomised controlled trial658.29 kBDownloadView
Accepted VersionCC BY-NC-ND V4.0 Open Access
url
https://doi.org/10.1194/jlr.P093013View
Published Version

Abstract

antioxidants arachidonic acid clinical trials diet and dietary lipids omega-3 fatty acids omega-3 Index abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) is an important cause of death in older adults which has no current drug therapy. Inflammation and abnormal redox status are believed to be key pathogenic mechanisms for AAA. In light of evidence correlating inflammation with aberrant fatty acid profiles, this study compared erythrocyte fatty acid content in 43 AAA patients (diameter 3.0-4.5 cm) and 52 healthy controls. In addition, the effect of omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation on erythrocyte fatty acid content was examined in a cohort of 30 AAA patients as part of a 12-week randomised placebo-controlled clinical trial. Blood analyses identified associations between AAA and decreased linoleic acid, and AAA and increased Δ6-desaturase activity and biosynthesis of arachidonic acid from linoleic acid. n-3 PUFA supplementation (1.5g DHA+0.3g EPA/day) decreased red blood cell distribution width (RDW, 14.8±0.4% to 13.8±0.2%, p=0.003) and levels of pro-inflammatory n-6 PUFAs (arachidonic acid, 12.46±0.23% to 10.14±0.3%, P<0.001; adrenic acid 2.12±0.13% to 1.23±0.09%, p<0.001). In addition, Δ4-desaturase activity increased (docosahexaenoic/docosapentaenoic acid ratio, 1.85±0.14 to 3.93±0.17, P<0.001) and elongase 2/5 activity decreased (adrenic acid/arachidonic acid ratio, 0.17±0.01 to 0.12±0.01, P<0.01) following supplementation. The findings suggest n-3 PUFAs improve fatty acid profiles and ameliorate factors associated with inflammation in AAA patients.

Details

Metrics

13 File views/ downloads
833 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Biochemistry & Molecular Biology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image